Expand to shield: IL-15 and in situ lymphocytic proliferation - Sorbonne Université
Journal Articles OncoImmunology Year : 2021

Expand to shield: IL-15 and in situ lymphocytic proliferation

Gabriela Bindea
Bernhard Mlecnik
Jérôme Galon
  • Function : Author
  • PersonId : 906063

Abstract

The tumor microenvironment includes a complex network of cytokines and chemokines that contribute to shaping the intratumoral immune reaction. Understanding the mechanisms leading to immune-hot (Immunoscore-high) altered (excluded and immunosuppressed) and cold tumors are of critical importance for successful anti-cancer therapies. Two essential mechanisms are highlighted. Specific chemokines and adhesion molecules appeared to target and attract immune effector T cells to the tumor microenvironment and to specific regions within the tumor. These mechanisms are dependent upon intratumoral IL-15 expression. Decreased IL15 expression also affected the local proliferation of B and T lymphocytes. A comprehensive analysis revealed a major contribution of IL15 in shaping the tumor immune contexture. Thus, an in situ lymphocytic infiltration is mediated through chemokines and attraction inside or around the tumor microenvironment, and an IL15-mediated in situ lymphocytic proliferation, which expand the local pool of intratumoral cytotoxic CD8 T-cells are key determinants of the immune contexture. Increased IL15 expression and local proliferation of T-cells were associated with decreased risk of tumor recurrence and prolonged survival of cancer patients. These data provide further mechanisms to prioritize research and help in designing better therapeutic interventions.
Fichier principal
Vignette du fichier
Expand to shield IL 15 and in situ lymphocytic proliferation.pdf (952.97 Ko) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03342859 , version 1 (13-09-2021)

Identifiers

Cite

Gabriela Bindea, Bernhard Mlecnik, Jérôme Galon. Expand to shield: IL-15 and in situ lymphocytic proliferation. OncoImmunology, 2021, 10 (1), pp.1886726. ⟨10.1080/2162402x.2021.1886726⟩. ⟨hal-03342859⟩
33 View
33 Download

Altmetric

Share

More